BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21569539)

  • 1. Renal tubular dysfunction measured by N-acetyl-beta glucosaminidase/Creatinine activity index in children receiving antiepileptic drugs: a randomized controlled trial.
    Mazaheri M; Samaie A; Semnani V
    Ital J Pediatr; 2011 May; 37():21. PubMed ID: 21569539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary N-acetyl-beta-glucosaminidase (NAG) in children receiving antiepileptic drugs.
    Tseng CL; Wang PJ; Tsau YK; Lin MY; Shen YZ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(4):251-6. PubMed ID: 1296433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study.
    Verrotti A; Greco R; Pascarella R; Matera V; Morgese G; Chiarelli F
    Epilepsia; 2000 Nov; 41(11):1432-5. PubMed ID: 11077456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary N-acetyl-beta-glucosaminidase and guanidinoacetic acid levels in epileptic patients treated with anti-epileptic drugs.
    Otsuka T; Sunaga Y; Hikima A
    Brain Dev; 1994; 16(6):437-40. PubMed ID: 7694990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-beta-D-glucosaminidase in epileptic children treated with antiepileptic drugs.
    Csáthy L; Oláh AV; Clemens B; György I; Varga J
    Arch Dis Child; 2000 Nov; 83(5):420-2. PubMed ID: 11040152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with epilepsy.
    Novo Mde L; Izumi T; Yokota K; Fukuyama Y
    Brain Dev; 1993; 15(2):157-60. PubMed ID: 8214337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of renal tubular function in children taking anti-epileptic treatment.
    Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E
    Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs.
    Yüksel A; Cengiz M; Seven M; Cengiz S; Cenani A
    Pediatr Neurol; 1999 Jan; 20(1):24-6. PubMed ID: 10029255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular dysfunction in epileptic children on valproic acid therapy.
    Altunbaşak S; Yildizaş D; Anarat A; Burgut HR
    Pediatr Nephrol; 2001 Mar; 16(3):256-9. PubMed ID: 11322374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tubular dysfunction following treatment with anti-epileptic drugs.
    Korinthenberg R; Wehrle L; Zimmerhackl LB
    Eur J Pediatr; 1994 Nov; 153(11):855-8. PubMed ID: 7843203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis.
    Skalova S; Rejtar P; Kutilek S
    Int Braz J Urol; 2007; 33(1):80-3; discussion 84-6. PubMed ID: 17335604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antiepileptic drugs on the kidney function and structure.
    Hamed SA
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):993-1006. PubMed ID: 28689437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for sodium valproate-induced renal tubular dysfunction.
    Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
    Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy?
    Havali C; Gücüyener K; Buyan N; Yılmaz Ü; Gürkaş E; Gülbahar Ö; Demir E; Serdaroğlu A
    J Child Neurol; 2015 Mar; 30(3):301-6. PubMed ID: 24958008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.
    Taşdemir M; Fuçucuoğlu D; Küçük SH; Erol M; Yiğit Ö; Bilge I
    Clin Exp Nephrol; 2018 Feb; 22(1):133-141. PubMed ID: 28653226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular function and urinary N-acetyl-β-d-glucosaminidase and kidney injury molecule-1 levels in asthmatic children.
    Demir AD; Goknar N; Oktem F; Özkaya E; Yazıcı M; Torun E; Vehapoğlu A; Kucukkoc M
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):626-631. PubMed ID: 27272162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate.
    Hamed SA; Rageh TA; Mohamad AO; Abou Elnour SM
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):819-824. PubMed ID: 30009654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary excretion of tubular enzymes and proteins in children with epilepsy.
    Korinthenberg R; Säger J; Zimmerhackl LB
    Eur J Paediatr Neurol; 2000; 4(6):263-7. PubMed ID: 11277367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.